↓ Skip to main content

A prospective, non-randomized phase II trial of Trastuzumab and Capecitabine in patients with HER2 expressing metastasized pancreatic cancer

Overview of attention for article published in BMC Surgery, January 2009
Altmetric Badge

Citations

dimensions_citation
17 Dimensions

Readers on

mendeley
50 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A prospective, non-randomized phase II trial of Trastuzumab and Capecitabine in patients with HER2 expressing metastasized pancreatic cancer
Published in
BMC Surgery, January 2009
DOI 10.1186/1471-2482-9-1
Pubmed ID
Authors

Andre Mihaljevic, Peter Büchler, Jan Harder, Ralf Hofheinz, Michael Gregor, Stephan Kanzler, Wolff Schmiegel, Volker Heinemann, Esther Endlicher, Günter Klöppel, Thomas Seufferlein, Michael Geissler

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 50 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 2%
Unknown 49 98%

Demographic breakdown

Readers by professional status Count As %
Researcher 14 28%
Student > Master 7 14%
Student > Bachelor 4 8%
Student > Ph. D. Student 4 8%
Student > Postgraduate 4 8%
Other 5 10%
Unknown 12 24%
Readers by discipline Count As %
Medicine and Dentistry 10 20%
Agricultural and Biological Sciences 10 20%
Psychology 4 8%
Nursing and Health Professions 3 6%
Pharmacology, Toxicology and Pharmaceutical Science 2 4%
Other 6 12%
Unknown 15 30%